These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32269940)

  • 1. Advanced liver imaging using MR to predict outcomes in chronic liver disease: a shift from morphology to function liver assessment.
    Verde F; Romeo V; Maurea S
    Quant Imaging Med Surg; 2020 Mar; 10(3):805-807. PubMed ID: 32269940
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver MRI: From basic protocol to advanced techniques.
    Donato H; França M; Candelária I; Caseiro-Alves F
    Eur J Radiol; 2017 Aug; 93():30-39. PubMed ID: 28668428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular nodules in liver cirrhosis: MR evaluation.
    Lee JM; Choi BI
    Abdom Imaging; 2011 Jun; 36(3):282-9. PubMed ID: 21399975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of primary sclerosing cholangitis: additional value of diffusion-weighted imaging and ADC measurement.
    Kovač JD; Ješić R; Stanisavljević D; Kovač B; Maksimovic R
    Acta Radiol; 2013 Apr; 54(3):242-8. PubMed ID: 23386736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional magnetic resonance imaging of the liver: parametric assessments beyond morphology.
    Koh DM; Padhani AR
    Magn Reson Imaging Clin N Am; 2010 Aug; 18(3):565-85, xii. PubMed ID: 21094456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.
    Hagiwara M; Rusinek H; Lee VS; Losada M; Bannan MA; Krinsky GA; Taouli B
    Radiology; 2008 Mar; 246(3):926-34. PubMed ID: 18195377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR imaging in chronic hepatitis and cirrhosis.
    Mortele KJ; Ros PR
    Semin Ultrasound CT MR; 2002 Feb; 23(1):79-100. PubMed ID: 11866224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging diagnosis of cirrhosis and chronic hepatitis.
    Ito K; Mitchell DG
    Intervirology; 2004; 47(3-5):134-43. PubMed ID: 15383722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging.
    Noone TC; Semelka RC; Siegelman ES; Balci NC; Hussain SM; Kim PN; Mitchell DG
    J Magn Reson Imaging; 2000 Jan; 11(1):44-50. PubMed ID: 10676619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging.
    Zhang XM; Mitchell DG; Shi H; Holland GA; Parker L; Herrine SK; Pasqualin D; Rubin R
    AJR Am J Roentgenol; 2002 Aug; 179(2):417-22. PubMed ID: 12130443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperechoic liver nodules: characterization with proton fat-water chemical shift MR imaging.
    Martín J; Puig J; Falcó J; Donoso L; Rué M; Sentís M; Darnell A; Musulén E
    Radiology; 1998 May; 207(2):325-30. PubMed ID: 9577476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis.
    Cassidy FH; Yokoo T; Aganovic L; Hanna RF; Bydder M; Middleton MS; Hamilton G; Chavez AD; Schwimmer JB; Sirlin CB
    Radiographics; 2009; 29(1):231-60. PubMed ID: 19168847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
    Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease: systemic and splanchnic venous flow mapping with optimized cine phase-contrast MR imaging validated in a phantom model and prospectively evaluated in patients.
    Gouya H; Vignaux O; Sogni P; Mallet V; Oudjit A; Pol S; Legmann P
    Radiology; 2011 Oct; 261(1):144-55. PubMed ID: 21771955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esophageal varices: diagnosis with gadolinium-enhanced MR imaging of the liver for patients with chronic liver damage.
    Matsuo M; Kanematsu M; Kim T; Hori M; Takamura M; Murakami T; Kondo H; Moriyama N; Nakamura H; Hoshi H
    AJR Am J Roentgenol; 2003 Feb; 180(2):461-6. PubMed ID: 12540452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonneoplastic liver disease: evaluation with CT and MR imaging.
    Kawamoto S; Soyer PA; Fishman EK; Bluemke DA
    Radiographics; 1998; 18(4):827-48. PubMed ID: 9672968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Fibrosis, Inflammation, and Steatosis: Influence on the MR Viscoelastic and Diffusion Parameters in Patients with Chronic Liver Disease.
    Leitão HS; Doblas S; Garteiser P; d'Assignies G; Paradis V; Mouri F; Geraldes CF; Ronot M; Van Beers BE
    Radiology; 2017 Apr; 283(1):98-107. PubMed ID: 27788034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New imaging techniques for liver diseases.
    Van Beers BE; Daire JL; Garteiser P
    J Hepatol; 2015 Mar; 62(3):690-700. PubMed ID: 25457198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focal manifestations of diffuse liver disease at MR imaging.
    Mitchell DG
    Radiology; 1992 Oct; 185(1):1-11. PubMed ID: 1523289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of measuring spleen stiffness with MR elastography and splenic volume to predict hepatic fibrosis stage.
    Cheng YW; Chang YC; Chen YL; Chen RC; Chou CT
    PLoS One; 2019; 14(5):e0217876. PubMed ID: 31150508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.